M&A Deal Summary

Medtronic Acquires Invatec

On January 25, 2010, Medtronic acquired medical products company Invatec for 500M USD

Acquisition Highlights
  • This is Medtronic’s 21st transaction in the Medical Products sector.
  • This is Medtronic’s 11th largest (disclosed) transaction.
  • This is Medtronic’s 19th transaction in the United States.
  • This is Medtronic’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2010-01-25
Target Invatec
Sector Medical Products
Buyer(s) Medtronic
Deal Type Add-on Acquisition
Deal Value 500M USD

Target

Invatec

Bethlehem, Pennsylvania, United States
website
Invatec is an innovator in the development and commercialization of interventional coronary and peripheral products, with global headquarters in Europe. Driven by research and technology, Invatec actively collaborates with physicians and centers of excellence to develop products that will improve life expectancy and quality of life for patients.

Search 193,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medtronic

Dublin, Ireland

website


Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 31.7B USD (2022)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. Medtronic serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.


DEAL STATS #
Overall 22 of 59
Sector (Medical Products) 21 of 52
Type (Add-on Acquisition) 22 of 57
State (Pennsylvania) 1 of 1
Country (United States) 19 of 44
Year (2010) 1 of 3
Size (of disclosed) 11 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-02-23 Ventor Technologies

Netanya, Israel

Ventor Technologies is a privately-held company based in Netanya, Israel. Dedicated to the development of minimally-invasive replacement aortic valves, Ventor has developed the transapically-implantable Ventor Embracer, which is under clinical investigation in Europe.

Buy $325M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-29 ATS Medical

Minneapolis, Minnesota, United States

ATS Medical, Inc., engages in the development, manufacture and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve and heart valve repair products. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, and it is developing minimally invasive and off-pump aortic valve concepts.

Buy $370M